OBJECTIVE: Oropharyngeal/laryngeal carcinoma are common cancers of the upper aerodigestive system. Human papillomavirus (HPV) is described as the most frequent in the cancer of unknown primary. The presence of Helicobacter pylori (HP) in the oral cavity is discussed in some papers. THE AIM OF STUDY: To analyze the incidence of HPV and HP in oropharyngeal/laryngeal cancer persons versus persons with chronic tonsillar inflammation and healthy persons. METHODS: The samples were taken in three groups: (1) tissue of oropharynx/larynx cancer (103 specimens); (2) tissue of palatine tonsils (85 specimens); and (3) healthy control group (50 specimens). We analyzed the presence of HP (PCR) and HPV genomic DNA (Sacace HPV High-Risk Screen Real-TM Quant) in the samples. RESULTS: HP was detected in 86 samples (83.5%) and high-risk HPV in 62 samples (60.2%). We found a very high incidence of HP. In the cancer group, HP was detected in 82.5% cases and HPV positivity in 57.8%. In total, 7.2% of the cancer patients were negative for HP and HPV together. In turn, 53.6% of the cancer patients were positive for HP and HPV together. Four cases (4.2%) were positive for HPV only. VacA positivity was detected in 82 (79.6%) of the cancer cases and VacA negativity in 21 (20.4%) if the cancer cases. The incidence of HP in chronic inflammation (n = 85) was 65 cases (76.5%) and the incidence of HPV was 38 cases (44.7%). VacA positivity was detected in 59 (69.4%) of the chronic inflammation cases and VacA negativity was found in 26 (30.6%) of the chronic inflammation cases. Regarding the control group, we found HP positivity in 5 cases (11.1%) and HPV positivity in 19 cases (42.2%). There was VacA positivity in 6 cases (50.0%) of the control group. Statistically significantly lower prevalence of HP (p < 0.001) and HPV (p = 0.006) was found in the control group. CONCLUSIONS: We suggest that the palatine tonsils are colonized by HP. In our study, HP was present in oropharyngeal cancer in more cases in comparison with HPV infection. The presence of VacA from HP can have an influence on the human epithelial and immune cells' regulation ways. Our results do not support idea that the CagA-positive HP is a primary carcinogen in oropharyngeal area.

1st Faculty of Medicine Charles University 12108 Prague Czech Republic

3rd Faculty of Medicine Charles University 10000 Prague Czech Republic

Department of Immunology and Microbiology and Department of Medical Biochemistry and Laboratory Diagnostics General University Hospital Prague 12808 Prague Czech Republic

Department of Otolaryngology Education Institute of Postgradual Medical Education 10005 Prague Czech Republic

Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Motol 15006 Prague Czech Republic

Department of Otorhinolaryngology and Maxilofacial Surgery Military University Hospital Prague 16902 Prague Czech Republic

Faculty of Biomedical Engineering Czech Technical University Prague 27201 Kladno Czech Republic

Maute HNO Praxis 85276 Pfaffenhofen an der Ilm Germany

Zobrazit více v PubMed

Genç R., Çağlı S., Yüce I., Vural A., Okuducu H., Patıroğlu T., Güney E. The Role ofH. pyloriin the Development of Laryngeal Squamous Cell Carcinoma. Dis. Markers. 2013;35:447–449. doi: 10.1155/2013/950701. PubMed DOI PMC

Karczewska E., Konturek J.E., Konturek P.C., Cześnikiewicz M., Sito E., Bielański W., Kwiecień N., Obtułowicz W., Ziemniak W., Majka J., et al. Oral cavity as a potential source of gastric reinfection by Helicobacter pylori. Dig. Dis. Sci. 2002;47:978–986. doi: 10.1023/A:1015017502772. PubMed DOI

Burduk P.K. Association between infection of virulence cagA gene Helicobacter pylori and laryngeal squamous cell carcinoma. Med. Sci. Monit. 2013;19:584–591. doi: 10.12659/MSM.889011. PubMed DOI PMC

Sivars L., Tani E., Näsman A., Ramqvist T., Munck-Wikland E., Dalianis T. Human Papillomavirus as a Diagnostic and Prognostic Tool in Cancer of Unknown Primary in the Head and Neck Region. Anticancer. Res. 2016;36:487–493. PubMed

Ramqvist T., Mints M., Tertipis N., Näsman A., Romanitan M., Dalianis T. Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters. Oral. Oncol. 2015;51:1126–1131. doi: 10.1016/j.oraloncology.2015.09.007. PubMed DOI

Lim Y., Totsika M., Morrison M., Punyadeera C. Oral Microbiome: A New Biomarker Reservoir for Oral and Oropharyngeal Cancers. Theranostics. 2017;7:4313–4321. doi: 10.7150/thno.21804. PubMed DOI PMC

Bulut Y., Agacayak A., Karlidag T., Toraman Z.A., Yilmaz M. Association of cagA+ Helicobacter pylori with Adenotonsillar Hypertrophy. Tohoku J. Exp. Med. 2006;209:229–233. doi: 10.1620/tjem.209.229. PubMed DOI

Pavlík E., Lukeš P., Potužníková B., Astl J., Hrdá P., Souček A., Matucha P., Doseděl J., Šterzl I. Helicobacter pylori isolated from patients with tonsillar cancer or tonsillitis chronica could be of different genotype compared to isolates from gastrointestinal tract. Folia. Microbiol. 2007;52:91–94. doi: 10.1007/BF02932145. PubMed DOI

Abdel-Monem M.H., Magdy E., Nour Y.A., Harfoush R.A., Ibreak A. Detection of Helicobacter pylori in adenotonsillar tissue of children with chronic adenotonsillitis using rapid urease test, PCR and blood serology: A prospective study. Int. J. Pediatric Otorhinolaryngol. 2011;75:568–572. doi: 10.1016/j.ijporl.2011.01.021. PubMed DOI

Lukes P., Astl J., Pavlík E., Potuzníková B., Sterzl I., Betka J. Helicobacter pylori in tonsillar and adenoid tissue and its possible role in oropharyngeal carcinogenesis. Folia. Biol. 2008;54:33–39. PubMed

Chen M., Fang Y., Cheng L., Wu H. Helicobacter pylori is associated with poor prognosis of laryngeal precancerous lesion. Auris. Nasus. Larynx. 2020;47:268–275. doi: 10.1016/j.anl.2019.08.004. PubMed DOI

Pandey S., Follin-Arbelet B., Pun C.B., Gautam D.K., Johannessen A.C., Petersen F.C., Costea D.E., Sapkota D. Helicobacter pylori was not detected in oral squamous cell carcinomas from cohorts of Norwegian and Nepalese patients. Sci. Rep. 2020;10:8737. doi: 10.1038/s41598-020-65694-7. PubMed DOI PMC

Fellmann J., Weisert J.U., Soltermann A., Morand G., Morra L., Moch H., Huber G.F., Probst R. Helicobacter pylori detected in pharyngeal and laryngeal pathologies in patients with proven gastric colonization. Head Neck. 2013;36:1562–1566. doi: 10.1002/hed.23492. PubMed DOI

Nártová E., Kraus J., Pavlik E., Lukeš P., Katra R., Plzák J., Kolářová L., Šterzl I., Betka J., Astl J. Presence of different genotypes of Helicobacter pylori in patients with chronic tonsillitis and sleep apnoea syndrome. Eur. Arch. Oto-Rhino-Laryngol. 2014;271:607–613. doi: 10.1007/s00405-013-2607-9. PubMed DOI

Rotnáglová E., Tachezy R., Salakova M., Procházka B., Košl’abová E., Vesela E., Ludvíková V., Hamšíková E., Klozar J. HPV involvement in tonsillar cancer: Prognostic significance and clinically relevant markers. Int. J. Cancer. 2011;129:101–110. doi: 10.1002/ijc.25889. PubMed DOI

Berman T.A., Schiller J.T. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer. 2017;123:2219–2229. doi: 10.1002/cncr.30588. PubMed DOI

Simonidesova S., Hamsikova E., Ludvikova V., Klozar J., Vencalek O., Tachezy R. Prognostic value of posttreatment HPV-specific antibodies in patients with oropharyngeal tumors. J. Surg. Oncol. 2019;120:117–124. doi: 10.1002/jso.25473. PubMed DOI

Timbang M.R., Sim M.W., Bewley A.F., Farwell D.G., Mantravadi A., Moore M.G. HPV-related oropharyngeal cancer: A review on burden of the disease and opportunities for prevention and early detection. Hum. Vaccines Immunother. 2019;15:1920–1928. doi: 10.1080/21645515.2019.1600985. PubMed DOI PMC

D’Souza G., McNeel T., Fakhry C. Understanding personal risk of oropharyngeal cancer: Risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann. Oncol. 2017;28:3065–3069. doi: 10.1093/annonc/mdx535. PubMed DOI PMC

Wittekindt C., Klussmann J.P. Tumor Staging and HPV-Related Oropharyngeal Cancer. Adv. Struct. Saf. Stud. 2016;206:123–133. doi: 10.1007/978-3-319-43580-0_9. PubMed DOI

Lukeš P., Pavlik E., Potužníková B., Plzák J., Nártová E., Doseděl J., Katra R., Šterzl I., Betka J., Astl J. Comparison of Helicobacter Pylori Genotypes Obtained from the Oropharynx and Stomach of the Same Individuals–A Pilot Study. Prague Med. Rep. 2012;113:231–239. doi: 10.14712/23362936.2015.21. PubMed DOI

Lukeš P., Pavlik E., Potuznikova B., Nartova E., Foltynova E., Plzák J., Katra R., Sterzl I., Bartunkova J., Betka J., et al. Detection of Helicobacter pylori in oropharyngeal lymphatic tissue with real-time PCR and assessment of its carcinogenic potential. Eur. Arch. Oto-Rhino-Laryngol. 2014;271:399–405. doi: 10.1007/s00405-013-2574-1. PubMed DOI

Katra R., Kabelka Z., Jurovcik M., Hradsky O., Kraus J., Pavlik E., Nartova E., Lukeš P., Astl J. Pilot study: Association between Helicobacter pylori in adenoid hyperplasia and reflux episodes detected by multiple intraluminal impedance in children. Int. J. Pediatric Otorhinolaryngol. 2014;78:1243–1249. doi: 10.1016/j.ijporl.2014.04.040. PubMed DOI

Chen J., Domingue J.C., Sears C.L. Microbiota dysbiosis in select human cancers: Evidence of association and causality. Semin. Immunol. 2017;32:25–34. doi: 10.1016/j.smim.2017.08.001. PubMed DOI PMC

Lopez E.M., Tanner A.M., Du E., Patel S.N., Weiss J., Weissler M.C., Hackman T., Gupta G.P., Zevallos J., Elmore S., et al. Decline in circulating viral and human tumor markers after resection of head and neck carcinoma. Head Neck. 2021;43:27–34. doi: 10.1002/hed.26444. PubMed DOI

De Martel C., Ferlay J., Franceschi S., Vignat J., Bray F., Forman D., Plummer M. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol. 2012;13:607–615. doi: 10.1016/S1470-2045(12)70137-7. PubMed DOI

Ang K.K., Harris J., Wheeler R., Weber R., Rosenthal D.I., Nguyen-Tân P.F., Westra W.H., Chung C.H., Jordan R.C., Lu C., et al. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer. N. Engl. J. Med. 2010;363:24–35. doi: 10.1056/NEJMoa0912217. PubMed DOI PMC

Payão L.T.R.S.L.M. Helicobacter pyloriand its reservoirs: A correlation with the gastric infection. World J. Gastrointest. Pharmacol. Ther. 2016;7:126–132. doi: 10.4292/wjgpt.v7.i1.126. PubMed DOI PMC

Hwang M.S., Forman S.N., Kanter J.A., Friedman M. Tonsillar Helicobacter pylori Colonization in Chronic Tonsillitis. JAMA Otolaryngol. Neck Surg. 2015;141:245. doi: 10.1001/jamaoto.2014.3296. PubMed DOI

Siupsinskiene N., Katutiene I., Jonikiene V., Janciauskas D., Vaitkus S. Helicobacter pylori in the tonsillar tissue: A possible association with chronic tonsillitis and laryngopharyngeal reflux. J. Laryngol. Otol. 2017;131:549–556. doi: 10.1017/S0022215117000597. PubMed DOI

Najafipour R., Ahmadpour F., Farivar T.N., Pahlevan A., Johari P., Safdarian F., Mehr M.A. Assessment of Helicobacter pylori prevalence by scorpion real-time PCR in chronic tonsillitis patients. J. Glob. Infect. Dis. 2012;4:38–42. doi: 10.4103/0974-777X.93760. PubMed DOI PMC

Song Q., Lange T., Spahr A., Adler G., Bode G. Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. J. Med. Microbiol. 2000;49:349–353. doi: 10.1099/0022-1317-49-4-349. PubMed DOI

Tang K.D., Vasani S., Menezes L., Taheri T., Walsh L.J., Hughes B.G., Frazer I.H., Kenny L., Scheper G.C., Punyadeera C. Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma. Cancer Sci. 2020;111:3854–3861. doi: 10.1111/cas.14585. PubMed DOI PMC

Hatakeyama M. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc. Jpn. Acad. Ser. B. 2017;93:196–219. doi: 10.2183/pjab.93.013. PubMed DOI PMC

Basso D., Navaglia F., Brigato L., Piva M.G., Toma A., Greco E., Di Mario F., Galeotti F., Roveroni G., Corsini A., et al. Analysis of Helicobacter pylori vacA andcagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut. 1998;43:182–186. doi: 10.1136/gut.43.2.182. PubMed DOI PMC

Miehlke S., Kirsch C., Agha-Amiri K., Günther T., Lehn N., Malfertheiner P., Stolte M., Ehninger G., Bayerdörffer E. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer. 2000;87:322–327. doi: 10.1002/1097-0215(20000801)87:3<322::AID-IJC3>3.0.CO;2-M. PubMed DOI

Fahimi F., Tohidkia M.R., Fouladi M., Aghabeygi R., Samadi N., Omidi Y. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy. BioImpacts. 2017;7:59–71. doi: 10.15171/bi.2017.08. PubMed DOI PMC

Chauhan N., Tay A.C.Y., Marshall B.J., Jain U. Helicobacter pyloriVacA, a distinct toxin exerts diverse functionalities in numerous cells: An overview. Helicobacter. 2019;24:e12544. doi: 10.1111/hel.12544. PubMed DOI

Caston R.R., Sierra J.C., Foegeding N.J., Truelock M.D., Campbell A.M., Frick-Cheng A.E., Bimczok D., Wilson K.T., McClain M.S., Cover T.L. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants. Infect. Immun. 2020;88:e00032-20. doi: 10.1128/IAI.00032-20. PubMed DOI PMC